Cita APA

Tolaney, S. M., Arteaga, C., Cortés Castan, J., Rugo, H., Bardia, A., & Sohn, J. (2020). TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2- metastatic breast cancer.

Citación estilo Chicago

Tolaney, Sara M., Carlos Arteaga, Javier Cortés Castan, Hope Rugo, Aditya Bardia, y Joohyuk Sohn. TROPiCS-02: A Phase III Study Investigating Sacituzumab Govitecan in the Treatment of HR+/HER2- Metastatic Breast Cancer. 2020.

Cita MLA

Tolaney, Sara M., et al. TROPiCS-02: A Phase III Study Investigating Sacituzumab Govitecan in the Treatment of HR+/HER2- Metastatic Breast Cancer. 2020.